DSIP has been evaluated in experimental frameworks examining stress-induced changes in neuroendocrine signaling
BPC 157 is primarily studied for tissue healing and anti-inflammatory effects
Range of motion around an injured joint or tendon increases as inflammation decreases and the local tissue environment improves
Reported Adverse Effects In the available case series and observational literature, the most commonly reported adverse effects include: Injection-site redness or mild induration in approximately 8 to 12% of users Transient nausea, most often associated with oral formulations or higher injectable doses Lightheadedness in a small number of patients shortly after injection (under 2% of reported cases) Vivid dreams or mild sleep changes, reported anecdotally by a subset of users with no clear mechanistic explanation No published human case reports as of July 2025 document serious organ toxicity, malignancy, or endocrine disruption attributable to BPC-157
This would benefit pets with Inflammatory bowel disease, environmental allergies, food allergies, chronic diarrhea, chronic vomiting, and other signs of GI upset or poor function
Synthesis and Release of Proinsulin and Insulin by Isolated Rat Islets of Langerhans